AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figure at a giant checklist

8 tips for strengthening your AMA Joy in Medicine application

| 14 Min Read
Businessperson signs documents while collaborating with a colleague

A strong advising team can help your private practice flourish

| 6 Min Read
Fruits and vegetables surround smartphone

Ditching the “SAD plate” to prevent and control chronic disease

| 7 Min Read
Margaretta Masse, MD, featured on "Health vs. Hype" AMA podcast

6 things patients should know about red light therapy

| 5 Min Read